Formulation design for topical drug and nanoparticle treatment of skin disease.
about
Eupafolin nanoparticles protect HaCaT keratinocytes from particulate matter-induced inflammation and oxidative stress.In Vivo Assessment of Clobetasol Propionate-Loaded Lecithin-Chitosan Nanoparticles for Skin Delivery.Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery.
P2860
Formulation design for topical drug and nanoparticle treatment of skin disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Formulation design for topical drug and nanoparticle treatment of skin disease.
@en
type
label
Formulation design for topical drug and nanoparticle treatment of skin disease.
@en
prefLabel
Formulation design for topical drug and nanoparticle treatment of skin disease.
@en
P2860
P50
P356
P1433
P1476
Formulation design for topical drug and nanoparticle treatment of skin disease.
@en
P2093
Gabriela Garrastazu
P2860
P304
P356
10.4155/TDE.14.106
P577
2015-02-01T00:00:00Z